跳至主要内容
临床试验/NL-OMON40615
NL-OMON40615招募中不适用

Hepatitis B vaccine efficacy in children exposed to anti-TNF in utero - HEFFIC study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • Study group: IBD mother must be treated with anti-TNF (infliximab or adalimumab) during (part of) the pregnancy
  • - Control group: IBD mother not treated with anti-TNF (any other IBD medication)
  • - Live birth

排除标准

  • - incapacity to understand the informed consent
  • - Maternal HBV, HCV or HIV infection
  • - Other immunecompromising conditions in the child
  • - not intending to vaccinate child according to the Dutch National Vaccination Programme in Dutch: *Nederlandse Rijksvaccinatieprogramma*

研究者

相似试验